BITPRISMIA
Sonnet BioTherapeutics' stock surged in pre-market trading following its agreement to form a new company, Hyperliquid Strategies Inc., with Rorschach I LLC, backed by prominent investors, marking a significant pivot into the cryptocurrency sector.